MYRIAD GENETICS SHAREHOLDER ALERT: ClaimsFiler Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline...
May 25 2018 - 10:50PM
Business Wire
ClaimsFiler, a FREE shareholder information service, reminds
investors that they have until June 19, 2018 to file lead
plaintiff applications in a securities class action lawsuit against
Myriad Genetics, Inc. (NasdaqGS: MYGN), if they purchased the
Company’s securities between August 13, 2014 through March 12,
2018, inclusive (the “Class Period”). This action is pending in the
United States District Court for the District of Utah.
Get Help
Myriad investors should visit us at
https://www.claimsfiler.com/cases/view-myriad-genetics-securities-litigation
or call to speak to our claim center toll-free at (844)
367-9658.
About the Lawsuit
Myriad Genetics and certain of its executives are charged with
failing to disclose material information during the Class Period,
violating federal securities laws.
On March 12, 2018, the Company revealed that it received a
subpoena from the Department of Health and Human Services,
regarding “an investigation into possible false or otherwise
improper claims submitted for payment under Medicare and Medicaid,”
specifically relating to the Company’s hereditary cancer testing
dating back to January 1, 2014 (less than four months after the
Company launched its myRisk test in September 2013) to the date of
the subpoena’s issuance.
On this news, the price of Myriad’s shares plummeted over
12.14%
About ClaimsFiler
ClaimsFiler has a single mission: to serve as the information
source to help retail investors recover their share of billions of
dollars from securities class action settlements. ClaimsFiler's
team of experts monitor the securities class action landscape and
cull information from a variety of sources to ensure comprehensive
coverage across a broad range of financial instruments.
To learn more about ClaimsFiler, visit www.claimsfiler.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20180525005675/en/
ClaimsFilerJerry Gallo,
844-367-9658https://www.claimsfiler.com
Myriad Genetics (NASDAQ:MYGN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Myriad Genetics (NASDAQ:MYGN)
Historical Stock Chart
From Apr 2023 to Apr 2024